Biosimilar Uptake in the US: Barriers, Breakthroughs, and Biologic...

добавлена новая статья Health

2025-06-17 13:16:01

Biosimilars, biologic products that are highly similar to already approved reference biologics, are reshaping the pharmaceutical landscape by offering cost-effective alternatives to high-priced biologics. While both the United States and the European Union recognize the value of biosimilars, their regulatory pathways, adoption rates, market penetration, and commercial challenges reveal distinct...

0 Комментарии 0 Поделились 292 Просмотры 0 предпросмотр